Supplementation ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
6Parkinson disease8

6. Parkinson disease


Clinical trials : 2,298 Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03568968
(ClinicalTrials.gov)
May 15, 202014/6/2018A Randomized Controlled Trial of Nicotinamide Supplementation in Early Parkinson's DiseaseA Randomized Controlled Trial of Nicotinamide Supplementation in Early Parkinson's Disease: the NOPARK StudyParkinson DiseaseDietary Supplement: Nicotinamide Riboside;Drug: PlaceboHaukeland University HospitalNULLRecruiting18 YearsN/AAll400N/ANorway
2NCT04044131
(ClinicalTrials.gov)
December 1, 201917/7/2019Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) PatientsA Phase 2, Randomized, Placebo Controlled Study to Evaluate the Efficacy, Tolerability and Safety of Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) And Parkinson's Disease (PD) PatientsAlzheimer Disease;Parkinson DiseaseDrug: Metabolic Cofactor Supplementation;Drug: SorbitolIstanbul Medipol University HospitalScandiBio Therapeutics AB;Alanya Alaaddin Keykubat University;Sahlgrenska University Hospital, Sweden;KTH Royal Institute of TechnologyRecruiting18 YearsN/AAll120Phase 2Turkey
3NCT04768023
(ClinicalTrials.gov)
November 18, 201914/2/202112 Weeks Vitamin D Supplementation and Physical Activity in PD Patients With DBSInfluence of 12 Weeks Vitamin D Supplementation Combined With Physical Activity on Blood and Functional Parameters and Quality of Life in Parkinson's Disease Patients Treated With Deep Brain StimulationVitamin D Deficiency;Parkinson DiseaseDrug: Juvit D3;Behavioral: steps per day;Drug: PlaceboMedical University of GdanskNULLEnrolling by invitation40 Years90 YearsAll72N/APoland
4NCT03816020
(ClinicalTrials.gov)
March 9, 20197/12/2018NAD-supplementation in Drug naïve Parkinson's DiseaseNAD-PARK: A Double-blinded Randomized Pilot Trial of NAD-supplementation in Drug naïve Parkinson's DiseaseParkinson Disease;Neurodegenerative DiseasesDietary Supplement: Nicotinamide Riboside;Other: PlaceboHaukeland University HospitalNULLCompleted18 YearsN/AAll30N/ANorway
5NCT03330470
(ClinicalTrials.gov)
January 1, 201717/10/2017Molecular Mediators of Physical Exercise and Carnosine Induced Effects in Patients With Preclinical and Early Stage Neurodegenerative DiseaseMolecular Mediators of Physical Exercise and Carnosine Induced Effects in Patients With Preclinical and Early Stage Neurodegenerative DiseaseSubjective Cognitive Impairment;Mild Cognitive Impairment;Parkinson Disease;Healthy VolunteersBehavioral: exercise;Dietary Supplement: carnosine supplementation;Behavioral: stretching;Dietary Supplement: supplementation with placeboSlovak Academy of SciencesComenius University;University Hospital Bratislava;National Cheng Kung UniversityRecruiting55 Years80 YearsAll100N/ASlovakia;Taiwan
6NCT00907972
(ClinicalTrials.gov)
September 200922/5/2009The Effects of Vitamin D and Bone Loss in Parkinson's DiseaseEffect of Vitamin D3 Supplementation in Parkinson's Disease Patients - A Pilot StudyParkinson DiseaseDietary Supplement: Vitamin D3;Other: PlaceboMemorial Medical CenterDepartment of DefenseCompleted18 YearsN/ABoth23Phase 2United States
7NCT01238926
(ClinicalTrials.gov)
May 20089/11/2010Vitamin B6, B12, Folic Acid and Exercise in Parkinson's DiseaseEffects of Vitamin Supplementation and Strength Training in Parkinson's DiseaseParkinson's DiseaseDietary Supplement: PD vitamin supplementation;Other: PD exercise intervention;Other: PD vitamin + exerciseNew York Institute of TechnologyStony Brook UniversityActive, not recruiting50 Years80 YearsBoth40N/AUnited States
8NCT00208611
(ClinicalTrials.gov)
September 200613/9/2005Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's DiseaseAssessment of Cobalamin Status and Responses to Supplementation in Patients With Parkinson's Disease : a Pilot StudyParkinson's DiseaseDietary Supplement: Vitamin B12 SupplementationEmory UniversityNational Institutes of Health (NIH)Terminated21 YearsN/ABoth57Phase 2/Phase 3United States